Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders

The ability to screen newborns for a larger number of disorders, including many with variable phenotypes, is prompting debate regarding the psychosocial impact of expanded newborn bloodspot screening (NBS) on parents. This study compares psychological outcomes of parents of children with a range of...

Full description

Bibliographic Details
Main Authors: Natalie A. Boychuk, Niamh S. Mulrooney, Nicole R. Kelly, Aaron J. Goldenberg, Ellen J. Silver, Melissa P. Wasserstein
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Neonatal Screening
Subjects:
Online Access:https://www.mdpi.com/2409-515X/8/4/59
_version_ 1797457191533281280
author Natalie A. Boychuk
Niamh S. Mulrooney
Nicole R. Kelly
Aaron J. Goldenberg
Ellen J. Silver
Melissa P. Wasserstein
author_facet Natalie A. Boychuk
Niamh S. Mulrooney
Nicole R. Kelly
Aaron J. Goldenberg
Ellen J. Silver
Melissa P. Wasserstein
author_sort Natalie A. Boychuk
collection DOAJ
description The ability to screen newborns for a larger number of disorders, including many with variable phenotypes, is prompting debate regarding the psychosocial impact of expanded newborn bloodspot screening (NBS) on parents. This study compares psychological outcomes of parents of children with a range of NBS/diagnostic experiences, with a particular focus on lysosomal storage disorders (LSDs) and X-linked adrenoleukodystrophy (X-ALD) as representative disorders with complex presentations. An online cross-sectional survey with six domains was completed in 2019 by a volunteer sample of parents with at least one child born between 2013 and 2018. Parents were classified in the analysis stage into four groups based on their child’s rare disorder and means of diagnosis. Stress and depression were estimated using dichotomous measures of the depression subscale of the Hospital Anxiety and Depression Scale and the Parental Stress Scale. Logistic regression models were estimated for the relationship between the parent group and stress/depression, controlling for demographic variables (region of the US, income, education, major life events, relationship to the child, number of children, parent age, and race/ethnicity). One hundred seventy-four parents were included in this analysis. Parents of children with an LSD or X-ALD diagnosis clinically may have higher odds of depression (OR: 6.06, 95% CI: 1.64–24.96) compared to parents of children with the same disorders identified through NBS, controlling for covariates. Although a similar pattern was observed for parental stress (OR: 2.85, 95% CI: 0.82–10.37), this did not reach statistical significance. Ethically expanding NBS and genome sequencing require an understanding of the impacts of early detection for complex disorders on families. These initial findings are reassuring, and may have implications as NBS expands. Given our small sample size, it is difficult to generalize these findings to all families. These preliminary trends warrant further investigation in larger and more diverse populations.
first_indexed 2024-03-09T16:17:35Z
format Article
id doaj.art-42c824b4aa7346ffa5ab85b823966a8f
institution Directory Open Access Journal
issn 2409-515X
language English
last_indexed 2024-03-09T16:17:35Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Neonatal Screening
spelling doaj.art-42c824b4aa7346ffa5ab85b823966a8f2023-11-24T15:35:26ZengMDPI AGInternational Journal of Neonatal Screening2409-515X2022-11-01845910.3390/ijns8040059Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset DisordersNatalie A. Boychuk0Niamh S. Mulrooney1Nicole R. Kelly2Aaron J. Goldenberg3Ellen J. Silver4Melissa P. Wasserstein5Department of Pediatrics, Albert Einstein College of Medicine and Children’s Hospital at Montefiore, Bronx, NY 10467, USADepartment of Pediatrics, Albert Einstein College of Medicine and Children’s Hospital at Montefiore, Bronx, NY 10467, USADepartment of Pediatrics, Albert Einstein College of Medicine and Children’s Hospital at Montefiore, Bronx, NY 10467, USADepartment of Bioethics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USADepartment of Pediatrics, Albert Einstein College of Medicine and Children’s Hospital at Montefiore, Bronx, NY 10467, USADepartment of Pediatrics, Albert Einstein College of Medicine and Children’s Hospital at Montefiore, Bronx, NY 10467, USAThe ability to screen newborns for a larger number of disorders, including many with variable phenotypes, is prompting debate regarding the psychosocial impact of expanded newborn bloodspot screening (NBS) on parents. This study compares psychological outcomes of parents of children with a range of NBS/diagnostic experiences, with a particular focus on lysosomal storage disorders (LSDs) and X-linked adrenoleukodystrophy (X-ALD) as representative disorders with complex presentations. An online cross-sectional survey with six domains was completed in 2019 by a volunteer sample of parents with at least one child born between 2013 and 2018. Parents were classified in the analysis stage into four groups based on their child’s rare disorder and means of diagnosis. Stress and depression were estimated using dichotomous measures of the depression subscale of the Hospital Anxiety and Depression Scale and the Parental Stress Scale. Logistic regression models were estimated for the relationship between the parent group and stress/depression, controlling for demographic variables (region of the US, income, education, major life events, relationship to the child, number of children, parent age, and race/ethnicity). One hundred seventy-four parents were included in this analysis. Parents of children with an LSD or X-ALD diagnosis clinically may have higher odds of depression (OR: 6.06, 95% CI: 1.64–24.96) compared to parents of children with the same disorders identified through NBS, controlling for covariates. Although a similar pattern was observed for parental stress (OR: 2.85, 95% CI: 0.82–10.37), this did not reach statistical significance. Ethically expanding NBS and genome sequencing require an understanding of the impacts of early detection for complex disorders on families. These initial findings are reassuring, and may have implications as NBS expands. Given our small sample size, it is difficult to generalize these findings to all families. These preliminary trends warrant further investigation in larger and more diverse populations.https://www.mdpi.com/2409-515X/8/4/59newborn screeningELSIpsychological
spellingShingle Natalie A. Boychuk
Niamh S. Mulrooney
Nicole R. Kelly
Aaron J. Goldenberg
Ellen J. Silver
Melissa P. Wasserstein
Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
International Journal of Neonatal Screening
newborn screening
ELSI
psychological
title Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
title_full Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
title_fullStr Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
title_full_unstemmed Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
title_short Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
title_sort parental depression and anxiety associated with newborn bloodspot screening for rare and variable onset disorders
topic newborn screening
ELSI
psychological
url https://www.mdpi.com/2409-515X/8/4/59
work_keys_str_mv AT natalieaboychuk parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders
AT niamhsmulrooney parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders
AT nicolerkelly parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders
AT aaronjgoldenberg parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders
AT ellenjsilver parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders
AT melissapwasserstein parentaldepressionandanxietyassociatedwithnewbornbloodspotscreeningforrareandvariableonsetdisorders